BioSpace News Archive

HealthTrackRx, the nation’s leading polymerase chain reaction (PCR) testing lab, is working in a partnership with the Centers for Disease Control and Prevention (CDC) to conduct an epidemiologic study to help to understand how widespread Monkeypox is within the United States.

Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced organizational updates and preliminary second quarter revenue.

Summit Therapeutics Inc. (NASDAQ: SMMT) today announced that it has commenced its previously-announced rights offering of up to $100 million of the Company’s common stock.

Acer Therapeutics Inc. today announced the resubmission of Acer’s New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for ACER-001 (sodium phenylbutyrate) for oral suspension for the treatment of patients with urea cycle disorders.

Werfen today announced the 510(k) clearance of the ROTEM sigma Thromboelastometry System by the US Food and Drug Administration (FDA).

During the COVID-19 pandemic, drug overdoses killed over 107,000 Americans in 2021. 1 Prior to the pandemic, Prime Therapeutics LLC (Prime), a leading pharmacy benefit manager (PBM) serving nearly 33 million members nationally, began an intervention program targeting Medicare members who were at high risk of overutilizing opioids.

Velodyne Lidar, Inc. (NASDAQ: VLDR, VLDRW), today announced that it will release its second quarter 2022 financial results for the period ended June 30, 2022, on Monday, August 8, 2022, after the market close.

Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, today announced that it has entered into a securities purchase agreement with certain accredited investors for a private placement transaction (the “Private Placement”).

RegeneRx Biopharmaceuticals, Inc. is reporting today that its U.S. joint venture (JV) partner and licensee, HLB Therapeutics (HLBT), has signed a letter of intent with a global ophthalmology contract research organization (CRO) to conduct two phase 3 clinical trials.

This week, Sonic Healthcare USA (Sonic) began testing for Monkeypox (MPXV), using the Centers for Disease Control and Prevention (CDC) Non-variola Orthopoxvirus, high complexity NAAT (RT-PCR) molecular assay.